The cystic fibrosis transmembrane conductance regulator (CFTR) and its stability

被引:48
|
作者
Meng, Xin [1 ]
Clews, Jack [1 ]
Kargas, Vasileios [1 ]
Wang, Xiaomeng [1 ]
Ford, Robert C. [1 ]
机构
[1] Univ Manchester, Fac Life Sci, Oxford Rd, Manchester M13 9PL, Lancs, England
关键词
CFTR; Membrane protein stability; Cystic fibrosis; Membrane protein structure; Biological detergent; MEMBRANE-PROTEINS; THERMAL-STABILITY; CHLORIDE CHANNEL; MUTANT CFTR; IN-VITRO; CRYO-EM; EXPRESSION; DETERGENT; PURIFICATION; POTENTIATOR;
D O I
10.1007/s00018-016-2386-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cystic fibrosis transmembrane conductance regulator (CFTR) is responsible for the disease cystic fibrosis (CF). It is a membrane protein belonging to the ABC transporter family functioning as a chloride/anion channel in epithelial cells around the body. There are over 1500 mutations that have been characterised as CF-causing; the most common of these, accounting for similar to 70 % of CF cases, is the deletion of a phenylalanine at position 508. This leads to instability of the nascent protein and the modified structure is recognised and then degraded by the ER quality control mechanism. However, even pharmacologically 'rescued' F508del CFTR displays instability at the cell's surface, losing its channel function rapidly and it is rapidly removed from the plasma membrane for lysosomal degradation. This review will, therefore, explore the link between stability and structure/function relationships of membrane proteins and CFTR in particular and how approaches to study CFTR structure depend on its stability. We will also review the application of a fluorescence labelling method for the assessment of the thermostability and the tertiary structure of CFTR.
引用
收藏
页码:23 / 38
页数:16
相关论文
共 50 条
  • [1] The cystic fibrosis transmembrane conductance regulator (CFTR) and its stability
    Xin Meng
    Jack Clews
    Vasileios Kargas
    Xiaomeng Wang
    Robert C. Ford
    [J]. Cellular and Molecular Life Sciences, 2017, 74 : 23 - 38
  • [2] Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis
    Parisi, Giuseppe Fabio
    Mollica, Federico
    Giallongo, Alessandro
    Papale, Maria
    Manti, Sara
    Leonardi, Salvatore
    [J]. EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2022, 23 (01)
  • [3] Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis
    Giuseppe Fabio Parisi
    Federico Mòllica
    Alessandro Giallongo
    Maria Papale
    Sara Manti
    Salvatore Leonardi
    [J]. Egyptian Journal of Medical Human Genetics, 23
  • [4] CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR)
    HIGGINS, CF
    [J]. BRITISH MEDICAL BULLETIN, 1992, 48 (04) : 754 - 765
  • [5] Pharmacology of CFTR (cystic fibrosis transmembrane conductance regulator)
    Cuthbert, A. W.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 22 - 22
  • [6] Purification and crystallization of the cystic fibrosis transmembrane conductance regulator (CFTR)
    Rosenberg, MF
    Kamis, AB
    Aleksandrov, LA
    Ford, RC
    Riordan, JR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (37) : 39051 - 39057
  • [7] Regulation of neurosecretion by the cystic fibrosis transmembrane conductance regulator (CFTR).
    Weyler, RT
    Altschuler, SM
    Mulberg, AE
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (03) : 207A - 207A
  • [9] Modelling studies of the cystic fibrosis transmembrane conductance regulator (CFTR)
    Ivetac, Anthony
    Campbell, Jeff
    Dawson, David C.
    Sansom, Mark S.
    [J]. BIOPHYSICAL JOURNAL, 2007, : 392A - 392A
  • [10] Cystic fibrosis: bacterial pathogenesis and CFTR (cystic fibrosis transmembrane conductance regulator) modulators
    Vargas-Roldan, Silvia Y.
    Lezana-Fernandez, Jose L.
    Cerna-Cortes, Jorge F.
    Partida-Sanchez, Santiago
    Santos-Preciado, Jose, I
    Rosales-Reyes, Roberto
    [J]. BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2022, 79 (04): : 215 - 221